BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2011
View Archived Issues
Pfizer's final two pivotal trials of tofacitinib in rheumatoid arthritis meet all primary endpoints
Read More
Ang-2-VEGF CrossMab simultaneously inhibits tumor growth and angiogenesis
Read More
Efficacy of linagliptin in type 2 diabetes is independent of body mass index
Read More
GBR-500 slows growth of prostate tumors in vivo
Read More
SAR-397769 eye drops show efficacy in model of age-related macular degeneration
Read More
New vitamin D receptor ligands disclosed
Read More
Topical AMA-0076 reduces intraocular pressure with low systemic exposure
Read More
SNP in CDKN2BAS locus correlates with susceptibility to Ph+ acute lymphoblastic leukemia
Read More
Bayer claims new hepatocyte growth factor receptor inhibitors
Read More
Centocor Ortho Biotech withdraws NDA for Yondelis in recurrent ovarian cancer
Read More
GSK patents new antiviral agents for HCV infection
Read More
RXi Pharma and UMMS receive grant to develop RNAi therapeutics for ALS
Read More
New PI3K-gamma inhibitors disclosed by Vertex Pharma
Read More
Jules Stein Eye Institute to be site in phase I/II MA-09-HRPE trials in macular degeneration
Read More
Avexxin designs novel cPLA2 inhibitors
Read More
Xenon Pharma reports phase IIa data on XEN-402 in postherpetic neuralgia
Read More
Apricus Biosciences files MAA in Europe for Vitaros to treat erectile dysfunction
Read More
EMA provides Keryx Biopharma with scientific advice on Zerenex in hyperphosphatemia
Read More
Boehringer Ingelheim and Lilly receive FDA approval for Tradjenta tablets in type 2 diabetes
Read More
AstraZeneca decides not to exercise option to license Targacept's TC-5619
Read More
QRxPharma completes enrollment in phase III MoxDuo IR study
Read More
Recordati launches pitavastatin in Spain for dyslipidemia
Read More
LCT receives approval to conduct phase II trial of Diabecell in Argentina
Read More
Ventrus adds third treatment arm to phase III iferanseri study in hemorrhoids
Read More
Prometheus obtains U.S. rights for Rencarex for clear cell renal cell carcinoma
Read More
Phase II data presented on Androxal in men with hypogonadism and type 2 diabetes
Read More